Skip to content 
Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Autism Impact Companies. The index is designed to measure the performance of publicly traded global companies in developed markets that provide products, services and/or research supporting the autism ecosystem comprised of individuals on the autism spectrum and within the broader neurodivergent community ("Autism Impact Companies"). It is non-diversified. more
| Time Frame | ASD | S&P500 |
|---|---|---|
| 1-Week Return | -0.77% | 0.42% |
| 1-Month Return | 1.6% | 4.46% |
| 3-Month Return | 12.53% | 5.11% |
| Stock name | Ticker | Weight |
|---|---|---|
 Neuren Pharmaceuticals Ltd | Neuren.Pharmaceuticals.Ltd | 4.26% |
 Definium Therapeutics Inc | DFTX | 4.21% |
 LifeStance Health Group Inc | LFST | 3.44% |
 Otsuka Holdings Co Ltd | Otsuka.Holdings.Co.Ltd | 3.27% |
 ACADIA Pharmaceuticals Inc | ACAD | 3.15% |
 Anavex Life Sciences Corp | AVXL | 3.07% |
 Repligen Corp | RGEN | 2.99% |
 Acadia Healthcare Co Inc | ACHC | 2.95% |
 BioMarin Pharmaceutical Inc | BMRN | 2.89% |
 Life Healthcare Group Holdings Ltd | Life.Healthcare.Group.Holdings.Ltd | 2.76% |
 Revvity Inc | PKI | 2.75% |
 Medicover AB | Medicover.AB | 2.68% |
 Bristol-Myers Squibb Co | BMY | 2.67% |
 Brainsway Ltd | BWAY | 2.65% |
 AbbVie Inc | ABBV | 2.63% |
 Bright Horizons Family Solutions Inc | BFAM | 2.6% |
 Johnson & Johnson | JNJ | 2.59% |
 Roche Holding AG | Roche.Holding.AG | 2.59% |
 Pearson PLC | Pearson.PLC | 2.55% |
 Takeda Pharmaceutical Co Ltd | Takeda.Pharmaceutical.Co.Ltd | 2.55% |
 Supernus Pharmaceuticals Inc | SUPN | 2.53% |
 Teva Pharmaceutical Industries Ltd | Teva.Pharmaceutical.Industries.Ltd | 2.51% |
 Jazz Pharmaceuticals PLC | JAZZ | 2.47% |
 Pfizer Inc | PFE | 2.44% |
 Graham Holdings Co | GHC | 2.41% |
 Eli Lilly & Co | LLY | 2.38% |
 Novartis AG | Novartis.AG | 2.37% |
 Ipsen SA | Ipsen.SA | 2.37% |
 Sumitomo Pharma Co Ltd | Sumitomo.Pharma.Co.Ltd | 2.37% |
 BrightSpring Health Services Inc | BTSG | 2.33% |
 Shionogi & Co Ltd | Shionogi...Co.Ltd | 2.31% |
 KPJ Healthcare Bhd | KPJ.Healthcare.Bhd | 2.3% |
 Grand Canyon Education Inc | LOPE | 2.27% |
 H Lundbeck A/S | H.Lundbeck.A.S | 2.27% |
 GSK PLC | GSK.PLC | 2.25% |
 Vanda Pharmaceuticals Inc | VNDA | 2.04% |
 Stride Inc | LRN | 2% |
 MapLight Therapeutics Inc | MPLT | 0.92% |
 First American Government Obligations Fund 12/01/2031 | First.American.Government.Obligations.Fund.12.01.2031 | 0.16% |
 Cash & Other | Cash...Other | 0.05% |
| Sector | Weight |
|---|---|
|
Health care | 88.35% |
|
Consumer staples | 4.11% |
|
Consumer discretionary | 2.61% |
|
Communication services | 2.53% |
|
Industrials | 2.40% |
Defiance Autism Impact ETF (ASD) share price today is $27.775.
Yes, Indians can buy shares of Defiance Autism Impact ETF (ASD) on Vested. To buy ASD from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Defiance Autism Impact ETF (ASD) on Vested. You can start investing in Defiance Autism Impact ETF (ASD) with a minimum investment of $1.
The 52-week high price of Defiance Autism Impact ETF (ASD) is $28. The 52-week low price of Defiance Autism Impact ETF (ASD) is $24.58.
The stock symbol (or ticker) of Defiance Autism Impact ETF is ASD.
Yes, you can setup SIP in Defiance Autism Impact ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of ASD on the Vested app.
The expense ratio of Defiance Autism Impact ETF (ASD) is .
Link copied 
